Atlas Trials

Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02924064 · COMPLETED

Trial details

NCT number
NCT02924064
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-09-01
Primary completion
2018-09-25
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.